{"entity":{"type":"insider","cik":"0001859453","url":"/insider/0001859453","json_url":"/insider/0001859453.json","name":"Fordyce Marshall","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":91,"n_filings":28,"first":"2022-08-15","last":"2026-08-12","span_basis":"filed_date"},"name_variants":[{"name":"Fordyce Marshall","source":"filing","n_filings":28,"first_seen":"2022-08-15","last_seen":"2026-08-12"}],"transactions":[{"id":9296536,"accession":"0001859453-26-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001859453-26-000013","line_url":"/filing/0001859453-26-000013","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001859453","owner_name":"Fordyce Marshall","owner_display_name":"Fordyce Marshall","owner_url":"/insider/0001859453","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46250.0,"shares_display":"46,250","price_per_share":42.29593772972973,"price_display":"42.30","price_state":"stated","total_value":1956187.12,"total_display":"1,956,187.12","total_whole":"1,956,187","shares_owned_after":280494.0,"shares_owned_after_display":"280,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-07","filed_date":"2026-08-12","scope":"insider","n_lines":4},{"id":6032226,"accession":"0001859453-26-000010","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001859453-26-000010","line_url":"/filing/0001859453-26-000010","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001859453","owner_name":"Fordyce Marshall","owner_display_name":"Fordyce Marshall","owner_url":"/insider/0001859453","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46250.0,"shares_display":"46,250","price_per_share":42.29593772972973,"price_display":"42.30","price_state":"stated","total_value":1956187.12,"total_display":"1,956,187.12","total_whole":"1,956,187","shares_owned_after":164694.0,"shares_owned_after_display":"164,694","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-07","filed_date":"2026-07-09","scope":"insider","n_lines":4},{"id":9296532,"accession":"0001859453-26-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001859453-26-000012","line_url":"/filing/0001859453-26-000012","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001859453","owner_name":"Fordyce Marshall","owner_display_name":"Fordyce Marshall","owner_url":"/insider/0001859453","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18500.0,"shares_display":"18,500","price_per_share":37.933473145945946,"price_display":"37.93","price_state":"stated","total_value":701769.2532,"total_display":"701,769.25","total_whole":"701,769","shares_owned_after":235332.0,"shares_owned_after_display":"235,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-23","filed_date":"2026-08-12","scope":"insider","n_lines":2},{"id":5753688,"accession":"0001859453-26-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001859453-26-000008","line_url":"/filing/0001859453-26-000008","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001859453","owner_name":"Fordyce Marshall","owner_display_name":"Fordyce Marshall","owner_url":"/insider/0001859453","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18500.0,"shares_display":"18,500","price_per_share":37.933473145945946,"price_display":"37.93","price_state":"stated","total_value":701769.2532,"total_display":"701,769.25","total_whole":"701,769","shares_owned_after":198332.0,"shares_owned_after_display":"198,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-23","filed_date":"2026-06-24","scope":"insider","n_lines":2},{"id":9296530,"accession":"0001859453-26-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001859453-26-000011","line_url":"/filing/0001859453-26-000011","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001859453","owner_name":"Fordyce Marshall","owner_display_name":"Fordyce Marshall","owner_url":"/insider/0001859453","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18500.0,"shares_display":"18,500","price_per_share":36.743084497297296,"price_display":"36.74","price_state":"stated","total_value":679747.0632,"total_display":"679,747.06","total_whole":"679,747","shares_owned_after":239525.0,"shares_owned_after_display":"239,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-12","filed_date":"2026-08-12","scope":"insider","n_lines":2},{"id":5779613,"accession":"0001859453-26-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001859453-26-000007","line_url":"/filing/0001859453-26-000007","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001859453","owner_name":"Fordyce Marshall","owner_display_name":"Fordyce Marshall","owner_url":"/insider/0001859453","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18500.0,"shares_display":"18,500","price_per_share":36.743084497297296,"price_display":"36.74","price_state":"stated","total_value":679747.0632,"total_display":"679,747.06","total_whole":"679,747","shares_owned_after":221025.0,"shares_owned_after_display":"221,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-12","filed_date":"2026-05-13","scope":"insider","n_lines":2},{"id":6009235,"accession":"0001859453-26-000006","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001859453-26-000006","line_url":"/filing/0001859453-26-000006","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001859453","owner_name":"Fordyce Marshall","owner_display_name":"Fordyce Marshall","owner_url":"/insider/0001859453","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22951.0,"shares_display":"22,951","price_per_share":44.05258173500065,"price_display":"44.05","price_state":"stated","total_value":1011050.8034,"total_display":"1,011,050.80","total_whole":"1,011,051","shares_owned_after":244065.0,"shares_owned_after_display":"244,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-14","filed_date":"2026-04-15","scope":"insider","n_lines":3},{"id":5900398,"accession":"0001859453-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001859453-26-000004","line_url":"/filing/0001859453-26-000004#line-1","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001859453","owner_name":"Fordyce Marshall","owner_display_name":"Fordyce Marshall","owner_url":"/insider/0001859453","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16925.0,"shares_display":"16,925","price_per_share":41.9839,"price_display":"41.98","price_state":"stated","total_value":710577.5075,"total_display":"710,577.51","total_whole":"710,578","shares_owned_after":257163.0,"shares_owned_after_display":"257,163","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-23","filed_date":"2026-02-25","scope":"insider"},{"id":4951676,"accession":"0001415889-25-005841","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-005841","line_url":"/filing/0001415889-25-005841","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001859453","owner_name":"Fordyce Marshall","owner_display_name":"Fordyce Marshall","owner_url":"/insider/0001859453","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9075.0,"shares_display":"9,075","price_per_share":27.64541212121212,"price_display":"27.65","price_state":"stated","total_value":250882.115,"total_display":"250,882.12","total_whole":"250,882","shares_owned_after":205765.0,"shares_owned_after_display":"205,765","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-26","filed_date":"2025-02-27","scope":"insider","n_lines":2},{"id":4951663,"accession":"0001415889-25-005841","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-005841","line_url":"/filing/0001415889-25-005841#line-1","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001859453","owner_name":"Fordyce Marshall","owner_display_name":"Fordyce Marshall","owner_url":"/insider/0001859453","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10613.0,"shares_display":"10,613","price_per_share":27.8933,"price_display":"27.89","price_state":"stated","total_value":296031.5929,"total_display":"296,031.59","total_whole":"296,032","shares_owned_after":213740.0,"shares_owned_after_display":"213,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-21","filed_date":"2025-02-27","scope":"insider"},{"id":4769124,"accession":"0001415889-25-001242","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001415889-25-001242","line_url":"/filing/0001415889-25-001242","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001859453","owner_name":"Fordyce Marshall","owner_display_name":"Fordyce Marshall","owner_url":"/insider/0001859453","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17500.0,"shares_display":"17,500","price_per_share":41.744878428571425,"price_display":"41.74","price_state":"stated","total_value":730535.3725,"total_display":"730,535.37","total_whole":"730,535","shares_owned_after":143603.0,"shares_owned_after_display":"143,603","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-08","filed_date":"2025-01-10","scope":"insider","n_lines":3},{"id":3238324,"accession":"0001415889-24-029964","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001415889-24-029964","line_url":"/filing/0001415889-24-029964","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001859453","owner_name":"Fordyce Marshall","owner_display_name":"Fordyce Marshall","owner_url":"/insider/0001859453","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17500.0,"shares_display":"17,500","price_per_share":43.06740356571429,"price_display":"43.07","price_state":"stated","total_value":753679.5624,"total_display":"753,679.56","total_whole":"753,680","shares_owned_after":85942.0,"shares_owned_after_display":"85,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-18","filed_date":"2024-12-20","scope":"insider","n_lines":5},{"id":2392831,"accession":"0001415889-24-029275","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001415889-24-029275","line_url":"/filing/0001415889-24-029275","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001859453","owner_name":"Fordyce Marshall","owner_display_name":"Fordyce Marshall","owner_url":"/insider/0001859453","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17500.0,"shares_display":"17,500","price_per_share":46.944188,"price_display":"46.94","price_state":"stated","total_value":821523.29,"total_display":"821,523.29","total_whole":"821,523","shares_owned_after":85942.0,"shares_owned_after_display":"85,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-11","filed_date":"2024-12-13","scope":"insider","n_lines":4},{"id":2449686,"accession":"0001415889-24-027840","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001415889-24-027840","line_url":"/filing/0001415889-24-027840","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001859453","owner_name":"Fordyce Marshall","owner_display_name":"Fordyce Marshall","owner_url":"/insider/0001859453","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19375.0,"shares_display":"19,375","price_per_share":47.97730452645161,"price_display":"47.98","price_state":"stated","total_value":929560.2752,"total_display":"929,560.28","total_whole":"929,560","shares_owned_after":85942.0,"shares_owned_after_display":"85,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-25","filed_date":"2024-11-27","scope":"insider","n_lines":5},{"id":2864336,"accession":"0001415889-24-026944","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001415889-24-026944","line_url":"/filing/0001415889-24-026944","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001859453","owner_name":"Fordyce Marshall","owner_display_name":"Fordyce Marshall","owner_url":"/insider/0001859453","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30625.0,"shares_display":"30,625","price_per_share":49.50326233142857,"price_display":"49.50","price_state":"stated","total_value":1516037.4089,"total_display":"1,516,037.41","total_whole":"1,516,037","shares_owned_after":85942.0,"shares_owned_after_display":"85,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-13","filed_date":"2024-11-15","scope":"insider","n_lines":9},{"id":2257310,"accession":"0001415889-24-025634","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001415889-24-025634","line_url":"/filing/0001415889-24-025634#line-8","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001859453","owner_name":"Fordyce Marshall","owner_display_name":"Fordyce Marshall","owner_url":"/insider/0001859453","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12715.0,"shares_display":"12,715","price_per_share":39.805,"price_display":"39.80","price_state":"stated","total_value":506120.575,"total_display":"506,120.58","total_whole":"506,121","shares_owned_after":307972.0,"shares_owned_after_display":"307,972","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-23","filed_date":"2024-10-25","scope":"insider"}],"collapsed":true,"next_cursor":"2024-10-23|2257310","ledger_fault":false,"count":{"value":91,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":91,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":91},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001831828","name":"Vera Therapeutics, Inc.","url":"/issuer/0001831828","role":"Director, Officer (PRESIDENT AND CEO)","n_filings":28,"first_seen":"2022-08-15","last_seen":"2026-08-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001859453","retrieved_at":"2026-08-27T07:22:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}